Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis

Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis

Aim: The study aimed to explore the incidence of cancer as an adverse event to SGLT2 inhibitors (SGLT2i) use in Type 2 diabetes.Materials & methods: The study followed PRISMA guidelines to pool RCTs conforming the inclusion criteria. Random effects model was used to pool risk ratios.Results &...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Ishtiaq Obaid, Mohammad Saiem Shahzad, Fakhar Latif, Muhammad Hamza Khan, Moeez Akram, Syed Asad Mehdi Rizvi, Rana Muhammad Umer Nasrullah, Dayab Asad, Muhammad Adil Obaid
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Future Science OA
Subjects:
antidiabetic medication
cancer incidence
cancer risk
diabetes mellitus
malignancy
meta-analysis
Online Access:https://www.tandfonline.com/doi/10.1080/20565623.2024.2400797
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/20565623.2024.2400797

Similar Items